outside of the Sanders-Brown Center on Aging building

Sanders-Brown Center on Aging

Card image

Mission & Vision

The mission of the Sanders-Brown Center on Aging (SBCoA) is to improve the health of the older adults in Kentucky and beyond through research dedicated to understanding the aging process and age-related brain diseases, and education, outreach, and clinical programs that promote
healthy brain aging.
The vision of SBCoA is to be be recognized locally and nationally as a premier, vitally productive and innovative aging center that effectively translates research findings into interventions and information that will benefit older adults.

Learn More

Translucent neurons on a dark blue background

Markesbury Scientific Session

Join the UK Sanders-Brown Center on Aging for the 14th annual Markesbery Symposium on Aging and Dementia, Scientific Session, to be held on Friday, September 27, 2024 from 12noon to 4:00pm. Our keynote speaker will be inflammation and cerebrovascular expert Dr. Charles DeCarli, University of California-Davis. In addition, University of Kentucky faculty, Drs. Lance Johnson and Erin Abner, will address the role of APOE in Alzheimer’s disease and the role of our Alzheimer’s Disease Research Center resources in facilitating research, respectively.

Register Today!
Campbell House

Markesbery Community Session

Join the UK Sanders-Brown Center on Aging for the 14th annual Markesbery Symposium on Aging and Dementia, Community Session, to be held on Saturday, September 28, 2024 from 8:00am to 12:30pm. Clinicians and researchers from Rush University, the University of California Davis, and the University of Kentucky will come together to share current findings, trends and the latest updates on dementia, particularly as related to Alzheimer’s disease and healthy brain aging. This is a hybrid event—in person at The Campbell House, Lexington, KY and via Zoom.

Register Today!
Card image

Drug studied at UK is first disease-modifying therapy in U.S. approved to treat Alzheimer’s

On July 6, 2023, the U.S. Food and Drug Administration (FDA) granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer’s disease. The University of Kentucky’s Sanders-Brown Center on Aging has been working with this drug and others like it for more than a decade.

Read the Full Story

75%
Increase in Funding
NIH funding to the Sanders-Brown Center on Aging increased from $13.3 million to $23.4 million in one year, a remarkable 75% increase in funding.
125
Employees
Beginning with only three faculty members, the Center has grown to more than 125 employees and to be one of the nation's leading centers on aging.

Learn More

Access the latest information about the Sanders-Brown Center on Aging on social media pages: Facebook   X (formerly Twitter)  YouTube

Listen to Sanders-Brown Center on Aging experts on the Mind Matters podcast on Spotify, Apple, and iHeart Media.